William D Hanley Selected Research

Cytomegalovirus Infections (Inclusion Disease)

1/2018

Pharmacokinetics and Exposure-Response Analysis of RG7667, a Combination of Two Anticytomegalovirus Monoclonal Antibodies, in a Phase 2a Randomized Trial To Prevent Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William D Hanley Research Topics

Disease

5	Infections 11/2020 - 01/2016
5	Neoplasms (Cancer) 01/2018 - 07/2005
2	Human Influenza (Influenza) 11/2020 - 01/2018
2	Macular Degeneration (Age-Related Maculopathy) 01/2019 - 10/2017
2	Renal Insufficiency (Renal Failure) 09/2017 - 05/2009
2	Neoplasm Metastasis (Metastasis) 02/2006 - 07/2005
2	Carcinoma (Carcinomatosis) 02/2006 - 07/2005
2	Inflammation (Inflammations) 05/2004 - 08/2003
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2019
1	Vitreous Hemorrhage 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Cytomegalovirus Infections (Inclusion Disease) 01/2018
1	Viremia 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Retinal Vein Occlusion 10/2017
1	Macular Edema 10/2017
1	Squamous Cell Carcinoma of Head and Neck 01/2016
1	Geographic Atrophy 11/2015
1	Asthma (Bronchial Asthma) 01/2012
1	Hyperglycemia 10/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2011
1	Hepatic Insufficiency 05/2009
1	Rupture 05/2004

Drug/Important Bio-Agent (IBA)

5	Monoclonal AntibodiesIBA 11/2020 - 10/2011
4	LigandsIBA 01/2016 - 05/2004
3	SelectinsIBA 02/2006 - 08/2003
2	gedivumabIBA 11/2020 - 01/2018
2	Ranibizumab (Lucentis)FDA Link 01/2019 - 10/2017
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2011
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2016
2	MEHD7945AIBA 01/2018 - 01/2016
2	Cetuximab (Erbitux)FDA Link 01/2018 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2016 - 05/2009
2	Lipoxygenase InhibitorsIBA 01/2012 - 03/2011
2	E-SelectinIBA 02/2006 - 07/2005
2	Membrane Proteins (Integral Membrane Proteins)IBA 02/2006 - 07/2005
2	adhesion receptorIBA 05/2004 - 08/2003
1	Oseltamivir (Tamiflu)FDA Link 11/2020
1	elbasvirIBA 01/2019
1	grazoprevirIBA 01/2019
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	RG7667IBA 01/2018
1	afliberceptIBA 10/2017
1	Bevacizumab (Avastin)FDA Link 10/2017
1	SugammadexIBA 09/2017
1	Neuregulin-1 (Neuregulin 1)IBA 01/2016
1	EnzymesIBA 11/2015
1	AntigensIBA 11/2015
1	Complement Factor D (Factor D)IBA 11/2015
1	lampalizumabIBA 11/2015
1	Leukotriene B4IBA 01/2012
1	LeukotrienesIBA 01/2012
1	Insulin (Novolin)FDA Link 10/2011
1	dalotuzumabIBA 10/2011
1	Metformin (Glucophage)FDA LinkGeneric 10/2011
1	CreatinineIBA 05/2009
1	Raltegravir Potassium FDA Link 05/2009
1	L-SelectinIBA 02/2006
1	Protein Isoforms (Isoforms)IBA 02/2006

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2016 - 10/2011
1	Operative Surgical Procedures 01/2019
1	Transplantation 01/2018
1	Microspheres (Microsphere) 02/2006